Latest News and Press Releases

2018 Focus for U.S. Expansion After Initial Success with NutriBullet LONDON, UNITED KINGDOM, May 09, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc. (OTC Markets: PLPL) (the...

Highly Bioavailable Formulation Efficiently Transfers Antioxidants LONDON, UNITED KINGDOM, May 03, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...

Natural Solution Provides Positive Mitigation Against Type 2 Diabetes LONDON, UNITED KINGDOM, May 01, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...

Company History in Cannabis Research Dates Back to February 2013 LONDON, UNITED KINGDOM, April 25, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...

LONDON, UNITED KINGDOM , April 19, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available...

Previously Issued Convertible Notes Now in Friendly Shareholder Hands LONDON, UNITED KINGDOM, April 12, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...

Human Clinical Trial Results and Key Benefits Phytofare Catechin Complex is Superior to Generic Green Tea Extracts LONDON, UNITED KINGDOM, April 10, 2018 (GLOBE NEWSWIRE) -- Plandai...

Phytofare Clinically Proven to Dramatically Improve Absorption LONDON, UNITED KINGDOM, April 03, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...

Performing Two Year Audit for Plandaí to Become Current and SEC Compliant LONDON, UNITED KINGDOM , March 27, 2018 (GLOBE NEWSWIRE) --   Plandaí Biotechnology Inc. (OTC Markets: PLPL) (the...

Looking to Ramp Commercialization and Accelerate Revenue Growth LONDON, UNITED KINGDOM, March 20, 2018 (GLOBE NEWSWIRE) -- Plandaí Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...